DOI QR코드

DOI QR Code

Effect of a Telephone-administered Cognitive Behavioral Therapy for the Management of Depression, Anxiety, and Chronic Illness Anticipated Stigma in Parkinson's Disease

파킨슨병 환자의 우울, 불안 및 만성질환에 기대되는 낙인 중재를 위한 전화사용 인지행동치료 효과

  • Bae, Eun Sook (Department of Nursing Science, Dong-Eui University) ;
  • Yeum, Dong Moon (Department of Social Welfare, International University of Korea)
  • 배은숙 (동의대학교 간호학과) ;
  • 염동문 (한국국제대학교 사회복지학과)
  • Received : 2015.02.24
  • Accepted : 2015.04.11
  • Published : 2015.04.30

Abstract

Purpose: Parkinson's disease (PD) has a high incidence of psychiatric comorbidity, specifically depression and anxiety. This study examined the effectiveness of group cognitive behavioral therapy (CBT) in treating depression and anxiety. Methods: The study included 42 participants, aged between 52 and 77 years, who were diagnosed with idiopathic Parkinson's disease (IPD) and reported suffering from depression and anxiety. Patients were attending a department of outpatient neurology at D University Schools of Medicine in B Metropolitan city. A structured telephone-administered cognitive behavioral therapy was conducted for eight weeks. A repeated measure ANOVA was used to analyze results at pretest, post-test, and four weeks follow up. Results: According to service method, there were significant differences between the two groups in depression, anxiety and stigma was significant difference between time (p<.05). Analysis of the interaction between time and service method revealed significant differences in depression and anxiety (p<.05). Conclusion: The results suggest that telephone-administered cognitive behavioral therapy may be effective and may provide opportunity to adapt to individual needs for treating depression and anxiety in patients with Parkinson's disease.

Keywords

References

  1. Pandya M1, Kubu CS, Giroux ML Parkinson's disease: not just a movement disorder. Cleveland Clinical Journal of Medicine. 2008;75(12):856-64. http://dx.doi.org/10.3949/ccjm.75a.07005
  2. McDonald WM, Righard IH, DeLong MR. Prevalence, etiology and treatment of depression in Parkinson's disease. Society of Biological Psychiatry. 2003;54(3):363-75. http://dx.doi.org/10.1016/S0006-3223(03)00530-4
  3. Cubo, E, Bernard B, Leurgans S, Raman R, Cognitive and motor function in patients with Parkinson's disease with and without depression. Clinical Neuropharmacology. 2000;23(6);331-4. https://doi.org/10.1097/00002826-200011000-00006
  4. Veazey C, Aki SOE, Cook KJ, Lai E, Kunik ME. Prevalence and treatment of depression in Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences. 2005;17(3):310-23. http://dx.doi.org/10.1176/jnp.17.3.310
  5. Veazy C, Cook KF, Stanley MLai, EC, Junik, ME. Telephoneadministered cognitive behavioral therapy: a case of anxiety and depression in Parkinson's disease. Journal of Clinical Psychologic Medical Settings. 2009;16:243-53. http://dx.doi.org/10.1007/s10880-009-9167-6
  6. Brooks DJ, Doder M. Depression in Parkinson's disease. Current Opinion in Neurology 2001;14:465-70. https://doi.org/10.1097/00019052-200108000-00006
  7. Starkstein S, Dragovic M, Jorge R, Brockman1 S, Merello M, Robinson RG, et al. Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis. Movement Disorders. 2011;26(12):2239-45. http://dx.doi.org/10.1002/mds.23836
  8. Ragnhild SH, Kjersti RL, Kathleen MG, Tom W, Martin E, Knut W, et al. The clinical effectiveness of web-based cognitive behavioral therapy with face-to-face therapist support for depressed primary care patients: randomized controlled trial. Journal of Medical Internet Research, 2013;15(8):e153. http://dx.doi.org/10.2196/jmir.2714
  9. Wrigley S, Jackson H, Judd F, Komiti A. The role of stigma and attitudes towards help seeking for mental health problems in a rural town, Australian & New Zealand Journal of Psychiatry. 2005;39(6):514-21. http://dx.doi.org/10.1111/j.1440-1614.2005.01612.x
  10. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stem MB. Recognition and treatment of depression in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology, 2003;16(3):178-83. http://dx.doi.org/10.1177/0891988703256053
  11. Shimotsu S, Horikawab N, Emurac R, Ishikawad SI, Nagaob A, Ogataf A, et al. Effectiveness of group cognitive-behavioral therapy in reducing self-stigma in Japanese psychiatric patients. Asian Journal of Psychiatry. 2014;10:39-44. http://dx.doi.org/10.1016/j.ajp.2014.02.006
  12. Simpson J, McMillan H, Reeve D. Reformulating psychological difficulties in people with Parkinson's disease: the potential of a social relational approach to disablism. Parkinson's Disease. 2013;Article ID 608562:1-8. http://dx.doi.org/10.1155/2013/608562
  13. Beck, J. S. Cognitive therapy: basics and beyond. New York: Guilford press. 1995.
  14. Chambless DL, Ollendick TH. Empirically supported psychologic intervention: controversies and evidence. Annual Review of Psycology. 2001;52:685-716. http://dx.doi.org/10.1177/10.1146/annurev.psych.52.1.685
  15. Yeh AH, Taylor S, Thordarson DS, Corcoran KM. Efficacy of telephone-administered cognitive behavioral therapy for obsessive-compulsive spectrum disorders: case studies. cognitive behavioral therapy, 2003;32(2):75-81. http://dx.doi.org/10.1080/16506070302323
  16. Ludman E, Simon GE, Tutty S, Von Korff M. A randomized trial of telephone psychotherapy and pharmacotherapy for depression: continuation durability of effects. Journal of Counselling and Clinical Psychology, 2007;75(2):257-66. http://dx.doi.org/10.1037/0022-006X.75.2.257
  17. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology.1967;17:427-42. https://doi.org/10.1212/WNL.17.5.427
  18. Fahn S. Marsden C, Jennifer P, Teychenne P. Eds. Recent development in Parkinson's disease. Florham Park NJ: Macmillan Health care Information. 1987;2
  19. Beck AT, Depression: clinical, experimental and theoretical aspects. New York: Harper & Row. 1967.
  20. Lee, YH. The relations between attributional style, life events, event attribution, hopelessness and depression. [dissertation]. Seoul National University; 1992.
  21. Spielberger CD. Manual for the State-trait anxiety inventory. Palo alto, CA, Consulting Psychologist Press. 1970.
  22. Kim JT. Correlation between trait anxiety and sociality: Spielberger's STA. [dissertation]. Seoul: Korea University: 1978
  23. Kurzban R, Leary MR. Evolutionary origins of stigmatization: the functions of social exclusion. Psychological Bulletin, 2001;127:187-208. http://dx.doi.org/ 10.1037/0033-2909.127.2.187
  24. Earnshaw VA, Quinn DM, Kalichman SC, Park CL. Development and psychometric evaluation of the chronic illness anticipated stigma scale. Journal of Behavioral Medicine. 2013; 36930:270-82. http://dx.doi.org/10.1007/s10865-012-9422-4
  25. Robert LL, Stephen JF. Lata KM. Treatment plans and interventions for depression and anxiety disorders. The Guilford Press; Second Edition: 2011.
  26. Yang S, Sajatovic M, Walter BL. Psychosocial intervention for depression and anxiety in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology. 2012;25(2):113-21. http://dx.doi.org/10.1177/0891988712445096
  27. Simmon GE, Ludman EJ, Opeskaliski BH, Randomized trial of telephone care management program: for outpatient starting antidepressant treatment. Psychiatric Services. 2006;57(10):1441-5. https://doi.org/10.1176/ps.2006.57.10.1441
  28. Dobkin RD, Allen LA, Menza M. Cognitive behavioral therapy for depression in Parkinson's disease: a pilot study. Movement Disorders. 2007;22(7):946-52. http://dx.doi.org/10.1002/mds.21455
  29. Dobkin RD, Allen LA, Menza M, Gara MA, Mark MH, Jade Tiu J. Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. America Journal of Psychiatry. 2011;168(10):1066-74. http://dx.doi.org/10.1176/appi.ajp.2011.10111669
  30. Cole K, Vaughan FL. The feasibility of using cognitive behavioral therapy for depression associated with Parkinson's disease: a literature review. Parkinsonism & Related Disorders. 2005;11(5):270-6. http://dx.doi.org/10.1016/j.parkreldis.2005.03.002

Cited by

  1. Personalized Telemedicine for Depression in Parkinson’s Disease: A Pilot Trial vol.31, pp.4, 2018, https://doi.org/10.1177/0891988718783274
  2. 파킨슨병에 대한 낙인에 영향을 미치는 요인 vol.32, pp.3, 2015, https://doi.org/10.14367/kjhep.2015.32.3.121
  3. Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment vol.131, pp.4, 2015, https://doi.org/10.1080/00207454.2020.1744591